Fidelity's continued 10.7% passive stake signals no near-term activist intent. Monitor for any future 13D conversion or material changes in ownership that could signal a shift in strategy.
Price Chart
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing a 10.7% passive stake in Celldex Therapeutics as of September 30, 2026, representing 8,411,905 shares. This is a routine quarterly update by a large asset manager with no change in passive intent, indicating continued institutional conviction.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 8,411,905 shares of Celldex common stock as of September 30, 2026.
- The stake represents 10.7% of outstanding shares.
- Fidelity Management & Research Company LLC is the entity that beneficially owns 5% or more of the class.
- The filing is an amendment to Schedule 13G, confirming passive investment intent under Rule 13d-1(b).
- No prior stake percentage was provided in the filing for comparison.
Financial Impact
FMR LLC's stake of 8,411,905 shares at 10.7% of outstanding shares — no transaction or change in intent disclosed.
Risk Factors
- No change in stake size or intent — filing is routine and provides no new catalyst.
- Passive 13G status means Fidelity cannot engage in activist activities without converting to 13D.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002325 |
| Document: 0000315066-26-002325-index-headers.html | 0000315066-26-002325 |
| Document: 0000315066-26-002325-index.html | 0000315066-26-002325 |
| Document: 0000315066-26-002325.txt | 0000315066-26-002325 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | SC 13G/A | $30.43 | awaiting T+60 | — | $30.15 (−0.92%) |
Sep 22, 2026 5w ago | Institutional Cluster | $33.51 | awaiting T+60 | — | $30.15 (−10.03%) |
Sep 22, 2026 5w ago | 8-K | $33.51 | awaiting T+60 | — | $30.15 (−10.03%) |
Sep 22, 2026 5w ago | Press Release | $33.51 | awaiting T+60 | — | $30.15 (−10.03%) |
Jun 14, 2026 19w ago | Press Release | $32.12 $38.10 | ▼ −18.62% | ▼ −18.22% | $30.15 (+6.13%) |
Jun 14, 2026 19w ago | Press Release | $32.12 $38.10 | ▲ +18.62% | ▲ +18.22% | $30.15 (−6.13%) |
Jun 11, 2026 19w ago | Institutional Cluster | $29.96 $39.12 | ▲ +30.57% | ▲ +26.75% | $30.15 (+0.63%) |
Jun 10, 2026 19w ago | Press Release | $29.96 $39.12 | ▲ +30.57% | ▲ +26.75% | $30.15 (+0.63%) |
May 7, 2026 24w ago | 8-K | $33.97 $39.05 | ▲ +14.95% | ▲ +10.11% | $30.15 (−11.25%) |
May 7, 2026 24w ago | Press Release | $33.97 $39.05 | ▲ +14.95% | ▲ +10.11% | $30.15 (−11.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers